Lates News

CervoMed (CRVO.US): The Q3 financial report for 2025 achieved revenue of $322,570, previous value was $1.94 million, and expected value was $1.14 million; earnings per share was -$0.84, previous value was -$0.55, and expected value was -$0.61.